[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-367878-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-367878-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","immunogenic-cell-death-related-risk-signature-for-tumor-microenvironment-profiling-and-prognostic-prediction-in-colorectal-cancer","Immunogenic cell death-related risk signature for tumor microenvironment profiling and prognostic prediction in colorectal cancer","","Immunogenic cell death (ICD) reshapes the tumor immune microenvironment and promotes adaptive immunity, yet ICD-associated genes’ clinical value in colorectal cancer (CRC) is not well defined. This study used WGCNA to discover ICD-related gene modules and built an ICD-related risk score (ICDRS) with Cox regression and LASSO. Immune infiltration was quantified via ESTIMATE and single-sample GSEA, and drug-sensitivity links were analyzed with oncoPredict. Three genes, CLMP, NRP1, and PLEKHO1, formed a prognostic model. High ICDRS independently predicted worse overall survival, showed greater immune infiltration, and correlated with chemosensitivity. In vitro assays validated differential expression and NRP1’s role in CRC proliferation, migration, and invasion.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/immunogenic-cell-death-related-risk-signature-for-tumor-microenvironment-profiling-and-prognostic-prediction-in-colorectal-cancer/367878/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/immunogenic-cell-death-related-risk-signature-for-tumor-microenvironment-profiling-and-prognostic-prediction-in-colorectal-cancer/367878.png","ImageObject",300,407,{"name":42,"@type":43},"Ben ","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",12,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How was the ICD-related risk signature constructed in this study?","Question",{"text":63,"@type":64},"WGCNA was used to identify ICD-related gene modules, and an ICD-related risk score (ICDRS) was built using Cox regression combined with LASSO analysis.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What clinical prognostic role did the ICDRS play in colorectal cancer?",{"text":68,"@type":64},"A high ICDRS was found to be an independent predictor of poorer overall survival (OS) in CRC patients.",{"name":70,"@type":61,"acceptedAnswer":71},"How did the ICDRS relate to chemotherapy drug sensitivity and immune infiltration?",{"text":72,"@type":64},"High-risk patients showed increased immune cell infiltration and the ICDRS significantly correlated with sensitivity to conventional chemotherapeutic drugs.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},367878,1790210664,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},2336478951081,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","RESEARCH ARTICLE  \nImmunogenic cell death-related risk signature for tumor microenvironment profiling and prognostic prediction in colorectal cancer  \nPengcheng Wang 1 ∗, Wei Zhao 2, Linghong Guo 1, and Hailei Cao 3  \nImmunogenic cell death (ICD) reshapes the tumor immune microenvironment and activates the adaptive immune response. However, the clinical significance of ICD-associated genes in colorectal cancer (CRC) remains unclear. In this study, we used weighted gene  \nco-expression network analysis (WGCNA) to identify ICD-related gene modules. An ICD-related risk score (ICDRS) was then constructed using Cox regression modeling and LASSO analysis. Immune cell infiltration in patients with different risk levels was assessed using the ESTIMATE and single-sample Gene Set Enrichment Analysis algorithms (GSEA). The oncoPredict package was employed to explore the association between the ICDRS and chemotherapy drug sensitivity. Finally, the expression levels of ICD-related genes were validated through in vitro cellular experiments. Three CRC prognostic genes—CLMP, Neuropilin-1 (NRP1), and PLEKHO1—were identified from a set of 34 ICD-associated genes based on WGCNA and LASSO analyses. These genes were used to construct the ICDRS model. Notably, a high ICDRS was found to be an independent predictor of poorer overall survival (OS) in CRC patients. High-risk patients also exhibited increased immune cell infiltration. Moreover, the ICDRS was significantly correlated with sensitivity to conventional chemotherapeutic drugs, suggesting its potential utility in guiding personalized chemotherapy. Cellular assays confirmed that CLMP, NRP1, and PLEKHO1 were differentially expressed between normal and cancerous cells, and that NRP1 specifically promoted the proliferation, migration, and invasion of CRC cells. In conclusion, the ICDRS may serve as a reliable predictor of CRC prognosis and offers a promising direction for the clinical management of CRC patients.  \nKeywords: Colorectal cancer, CRC, drug resistance, prognostic signature, immunogenic cell death, ICD, tumor immune microenvironment, TIME, cancer.  \nIntroduction  \nColorectal cancer (CRC) ranks as the third most frequently diagnosed cancer worldwide. Its annual incidence has reached 1.9 million cases, accounting for approximately 10% of all newly diagnosed cancers globally. Notably, there is a rapid rise in CRC incidence among younger populations in both developed and developing regions [1, 2] . The progression of CRC is a complex, multistep process involving various genetic alterations. CRC cells display distinct biological behaviors, including aggressive proliferation, a high tendency for relapse, and the potential to metastasize [3, 4] . Despite advances in treatment, CRC survival rates remain poor [5–7], highlighting the urgent need for novel prognostic, therapeutic, and diagnostic biomarkers.  \nImmunogenic cell death (ICD) is a form of cell death [8, 9] characterized by an active interaction between immune cells and dying cells, representing a key mode of communication between the immune system and tumor cells [10]. ICD primarily  \noccurs through apoptosis, during which damage-associated molecular patterns (DAMPs) are released from tumor cells. These DAMPs are recognized by NOD-like receptors (NLRs) and innate immune receptors such as Toll-like receptors (TLRs), triggering immune responses that speciﬁcally target tumor cells. This dual mechanism—directly killing cancer cells while enhancing antitumor immunity—can both promote and prolong the eﬀectiveness of chemotherapeutic drugs [11, 12]. A previous study developed and validated an ICD risk signature for lower-grade glioma based on the expression, function, and genetic alterations of 34 ICD-associated genes, ultimately identifying a 12-gene signature [13] . Additionally, two ICD-related subtypes were identiﬁed using consensus clustering, and an ICD-associated prognostic model was established to predict survival in patients with he","cbCaioD5Vnmi9ffC","https://ap.wps.com/l/cbCaioD5Vnmi9ffC","pdf",6669836,14,"English","# Introduction\n## Immunogenic cell death (ICD) and immune interactions\n## Rationale for ICD-associated biomarkers in CRC","[{\"question\":\"How was the ICD-related risk signature constructed in this study?\",\"answer\":\"WGCNA was used to identify ICD-related gene modules, and an ICD-related risk score (ICDRS) was built using Cox regression combined with LASSO analysis.\"},{\"question\":\"What clinical prognostic role did the ICDRS play in colorectal cancer?\",\"answer\":\"A high ICDRS was found to be an independent predictor of poorer overall survival (OS) in CRC patients.\"},{\"question\":\"How did the ICDRS relate to chemotherapy drug sensitivity and immune infiltration?\",\"answer\":\"High-risk patients showed increased immune cell infiltration and the ICDRS significantly correlated with sensitivity to conventional chemotherapeutic drugs.\"}]","Immunogenic cell death-related risk signature for tumor microenvironment profiling and prognostic prediction in colorectal cancer | PDF",1790173134,35,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/45e2ec36f8680470722798642fb45c8a.webp",983,1272,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a0c65fd3f2afa131d075fdcdc33c4ef9.webp",982,1270,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3f68dad0f33c1fa5f2f73867997d31b0.webp",981,1269,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/392810d95229482c24c60c15ab249b15.webp",980,1268]